1. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase
   Polly Gravells et al, 2017, DNA Repair CrossRef
2. Fumonisin B1 induces poly (ADP-ribose) (PAR) polymer-mediated cell death (parthanatos) in neuroblastoma
   Souren Paul et al, 2021, Food and Chemical Toxicology CrossRef
3. The recognition and removal of cellular poly(ADP‐ribose) signals
   Eva Barkauskaite et al, 2013, The FEBS Journal CrossRef
4. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
   Arnab Ray Chaudhuri et al, 2017, Nature Reviews Molecular Cell Biology CrossRef
5. Dimethylnitrosamine-Induced Reduction in the Level of Poly-ADP-Ribosylation of Histone Proteins of Blood Lymphocytes - a Sensitive and Reliable Biomarker for Early Detection of Cancer
   Lakhan Kma et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
6. Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation
   Xuan Li et al, 2016, PLOS ONE CrossRef
7. Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response
   Michael Tallis et al, 2014, Chromosoma CrossRef
8. PARG is dispensable for recovery from transient replicative stress but required to prevent detrimental accumulation of poly(ADP-ribose) upon prolonged replicative stress
   Giuditta Illuzzi et al, 2014, Nucleic Acids Research CrossRef
9. Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy
   Shivangi Patel et al, 2022, Metabolic Brain Disease CrossRef
10. Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib
    Polly Gravells et al, 2018, DNA Repair CrossRef
11. PARP Trapping Beyond Homologous Recombination and Platinum Sensitivity in Cancers
    Junko Murai et al, 2019, Annual Review of Cancer Biology CrossRef
12. PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency
    Aurélia Noll et al, 2016, Cancer Cell International CrossRef
13. PARP and PARG inhibitors in cancer treatment
    Dea Slade, 2020, Genes & Development CrossRef